Ellex Medical Lasers Limited announced the resignation of Mr. Malcolm Plunkett as a Director of the Company. Throughout his four and a half year tenure as a Director, Mr. Plunkett has been a full time executive in the business responsible for research and development and has made a significant contribution to the business. He will continue in this executive role concentrating on bringing the 2RT project through to market release and managing the business's research portfolio.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.225 AUD | +4.65% | +2.27% | -6.25% |
03-15 | Nova Eye Medical Completes Retail Entitlement Offer | MT |
02-22 | Nova Eye Medical Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.25% | 34.04M | |
+7.77% | 218B | |
+10.16% | 189B | |
+26.21% | 151B | |
+32.78% | 113B | |
+1.98% | 64.02B | |
+14.48% | 52.6B | |
+2.92% | 49.85B | |
-6.60% | 37.89B | |
-1.07% | 34.92B |
- Stock Market
- Equities
- EYE Stock
- News Nova Eye Medical Limited
- Ellex Medical Lasers Limited Announces the Resignation of Malcolm Plunkett as A Director